A bill to require manufacturers of drugs to post the names of the countries in which their drugs are manufactured on their internet websites.

United States115th CongressS-3105Senate
Updated: Jun 21, 2018

Summary

Pharmaceutical Origin Transparency Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to require a drug manufacturer to publish information about each country in which its drugs are manufactured. (A drug is manufactured in a country if the active pharmaceutical ingredient is manufactured in such country.)

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate

All available records shown.